UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity - Application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2

Human Mutation

Volumn 30, Issue 6, 2009, Pages 952-959

  Frédéric, Mélissa Yana ^a,b   Lalande, Marine ^a   Boileau, Catherine ^a,c   Hamroun, Dalil ^a,d   Claustres, Mireille ^a,b,d   Béroud, Christophe ^a,b,d   Collod Béroud, Gwenaëlle ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Bioinformatics; Missense mutation; Pathogenicity; Prediction tool

Indexed keywords

MESSENGER RNA;

AMINO ACID SUBSTITUTION; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FBN1 GENE; FBN2 GENE; GENE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TGFBR1 GENE; TGFBR2 GENE;

AMINO ACID SUBSTITUTION; ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; HUMANS; MICROFILAMENT PROTEINS; MUTATION, MISSENSE; NUCLEOTIDES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SOFTWARE;

CITRUS MAXIMA;

EID: 66349136835     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20970     Document Type: Article

References (35)

1. Ades LC, Sullivan K, Biggin A, Haan EA, Brett M, Holman KJ, Dixon J, Robertson S, Holmes AD, Rogers J, Bennetts B. 2006. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am J Med Genet A 140A:1047-1058.
2. Beroud C, Collod-Beroud G, Boileau C, Soussi T, Junien C. 2000. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 15:86-94. (Pubitemid 30036174)
3. Beroud C, Hamroun D, Collod-Beroud G, Boileau C, Soussi T, Claustres M. 2005. UMD (Universal Mutation Database): 2005 update. Hum Mutat 26:184-191. (Pubitemid 41254373)
4. Bromberg Y, Rost B. 2007. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35:3823-3835. (Pubitemid 47244674)
5. Cartegni L, Chew S, Krainer A. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-298. (Pubitemid 34279797)
6. Collod G, Beroud C, Soussi T, Junien C, Boileau C. 1996. Software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res 24:137-140. (Pubitemid 26085751)
7. Collod-Beroud G, Beroud C, Ades L, Black C, Boxer M, Brock DJ, Godfrey M, Hayward C, Karttunen L, Milewicz D, Peltonen L, Richards RI, Wang M, Junien C, Boileau C. 1997. Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res 25:147-150. (Pubitemid 27303172)
8. Collod-Beroud G, Beroud C, Ades L, Black C, Boxer M, Brock DJ, Holman KJ, de Paepe A, Francke U, Grau U, Hayward C, Klein HG, Liu W, Nuytinck L, Peltonen L, Alvarez Perez AB, Rantamäki T, Junien C, Boileau C. 1998. Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res 26:223-229. (Pubitemid 28300706)
9. Collod-Beroud G, Le Bourdelles S, Ades L, Ala-Kokko L, Booms P, Boxer M, Child A, Comeglio P, De Paepe A, Hyland JC, Holman K, Kaitila I, Loeys B, Matyas G, Niuytinck L, Peltonen L, Rananmaki T, Robinson P, Steinmann B, Junien C, Béroud C, Boileau C. 2003. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat 22:199-208. (Pubitemid 37071636)
10. Dietz H, Pyeritz R. 1995. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 4(Spec No): 1799-1809.
11. Downing A, Knott V, Werner J, Cardy C, Campbell I, Handford P. 1996. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85:597-605. (Pubitemid 126334347)
12. Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Deroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Adès LC, Biggin A, Benetts B, Brett M, Holman KJ, DeBacker J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C. 2007. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 81:454-466. (Pubitemid 47330205)
13. Frederic MY, Hamroun D, Faivre L, Boileau C, Jondeau G, Claustres M, Beroud C, Collod-Beroud G. 2008a. A new locus-specific database (LSDB) for mutations in the TGFBR2 gene: UMD-TGFBR2. Hum Mutat 29:33-38.
14. Frederic MY, Monino C, Marschall C, Hamroun D, Faivre L, Jondeau G, Klein H-G, Neumann L, Gautier E, Binquet C, Maslen C, Godfrey M, Gupta P, Milewitz D, Boileau C, Claustres M, Béroud C, Collod-Béroud G. 2008b. FBN2 gene: new mutations, locus specific database (UMD-FBN2) and genotype-phenotype correlations. Human Mutation 30:181-190.
15. Henikoff S, Henikoff JG. 1992. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 89:10915-10919.
16. Hindson V, Ashworth J, Rock M, Cunliffe S, Shuttleworth C, Kielty C. 1999. Fibrillin degradation by matrix metalloproteinases: identification of amino- and carboxy-terminal cleavage sites. FEBS Lett 452:195-198. (Pubitemid 29301743)
17. Krahn M, Béroud C, Labelle V, Nguyen K, Bernard R, Bassez G, Figarella-Branger D, Fernandez C, Bouvenot J, Richard I, Ollagnon-Roman E, Bevilacqua JA, Salvo E, Attarian S, Chapon F, Pellissier JF, Pouget J, Hammouda el H, Laforêt P, Urtizberea JA, Eymard B, Leturcq F, Lévy N. 2009. Hum Mut 30:E345-E375.
18. Kruglyak L, Nickerson DA. 2001. Variation is the spice of life. Nat Genet 27:234-236. (Pubitemid 32201838)
19. Lonnqvist L, Reinhardt D, Sakai L, Peltonen L. 1998. Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations. Hum Mol Genet 7:2039-2044. (Pubitemid 28546411)
20. Luo K, Lodish H. 1997. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J 16:1970-1981. (Pubitemid 27170958)
21. Matyas G, Arnold E, Carrel T, Baumgartner D, Boileau C, Berger W, Steinmann B. 2006. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27:760-769. (Pubitemid 44205069)
22. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. 2004. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36:855-860. (Pubitemid 39014103)
23. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11:863-874. (Pubitemid 32447869)
24. Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814. (Pubitemid 37442253)
25. Pannu H, Fadulu V, Chang J, Lafont A, Hasham S, Sparks E, Giampietro P, Zaleski C, Estrera A, Safi H, Shete S, Willing MC, Raman CS, Milewicz DM. 2005. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112:513-520. (Pubitemid 41060791)
26. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900.
27. Reinhardt DP, Sasaki T, Dzamba BJ, Keene DR, Chu ML, Gohring W, Timpl R, Sakai LY. 1996. Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem 271:19489-19496. (Pubitemid 26271623)
28. Ritty TM, Broekelmann TJ, Werneck CC, Mecham RP. 2003. Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment. Biochem J 375(Pt 2):425-432. (Pubitemid 37315450)
29. Rommel K, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. 2002. Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations. Hum Mutat 20:406-407.
30. Sarkozy A, Bushby K, Beroud C, Lochmuller H. 2008. 157th ENMC International Workshop: patient registries for rare, inherited muscular disorders 25-27 January 2008 Naarden, The Netherlands. Neuromuscul Disord 18:997-1001.
31. Senapathy P, Shapiro MB, Harris NL. 1990. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278. (Pubitemid 20148824)
32. Shapiro MB, Senapathy P. 1987. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174.
33. Stheneur C, Collod-Beroud G, Faivre L, Gouya L, Sultan G, Le Parc JM, Moura B, Attias D, Muti C, Sznajder M, Claustres M, Junien C, Baumann C, Cormier-Daire V, Rio M, Lyonnet S, Plauchu H, Lacombe D, Chevallier B, Jondeau G, Boileau C. 2008. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 29:E284-E295.
34. Tchernitchko D, Goossens M, Wajcman H. 2004. In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clin Chem 50:1974-1978.
35. Yu K. 2001. Theoretical determination of amino acid substitution Groups based on qualitative physicochemical properties. http://cmgm.stanford.edu/ biochem218/Projects%202001/Yu.pdf.